ArticleJACC. Case reports2026
Transapical Mitral TEER and Aortic Regurgitation TAVR With Dedicated Device in a Patient With Extreme Scoliosis.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundConcomitant aortic and mitral regurgitation (CAMR) is a rare valvulopathy, seen in patients with scoliosis, and rarely involves aortic regurgitation with concomitant primary mitral regurgitation associated with poor prognosis when left untreated. Current guidelines lack robust evidence to guide the management of CAMR in complex anatomies such as extreme scoliosis. CASE SUMMARY: We report the first case of a one-stage transcatheter intervention for CAMR in a 62-year-old man with extreme scoliosis. The patient underwent one-stage transapical mitral transcatheter edge-to-edge repair (mTEER) and on-label transcatheter aortic valve replacement to reduce surgical risk in high-risk patients. Despite significant anatomical challenges, the procedure was completed successfully without complications. CONCLUSION AND TAKE-HOME MESSAGES: CAMR in patients with severe scoliosis poses high operative risk, but a one-stage transapical approach using dedicated mTEER and transcatheter aortic valve replacement is a feasible, effective strategy. An mTEER-first strategy enables hemodynamic stabilization and precise leaflet grasping. This case underscores the value of individualized transcatheter strategies to achieve safe and effective outcomes in complex valvular disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.